Prediction Case File
YouTubeTracking Live

Alibaba: ventas +10% y beneficio +92%

1 extracted signal · 0 resolved · 1 still active

Alex Dito - Invertir en Valor profile imageAlex Dito - Invertir en ValorIndependent analyst profile
Source published
21 Nov 2026, 05:48 UTC
Recorded by Tahlil Plus
21 Nov 2026, 12:25 UTC
Video preview for Alibaba: ventas +10% y beneficio +92%
Source overview

AI-generated source summary

Alibaba reported stellar quarterly results with a 10 percent increase in sales and a 92 percent surge in adjusted net income, signaling a definitive end to the company's prior earnings decline. The speaker highlights strong operational growth across its e-commerce divisions, international expansion, and ongoing investments in logistics and artificial intelligence, establishing a fundamentally bullish outlook for the stock.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Alex Dito - Invertir en Valor

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
50
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail